Entero Therapeutics Inc.

NASDAQ: ENTO
Share price (1/8/25): $0.62
Market cap (1/8/25): $2.947 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from DEFA14A 133 pages Agreement and Plan of Merger Among: First Wave Biopharma, Inc.; Immuno Merger Sub I, Inc.; Immuno Merger Sub II, LLC; and Immunogenx, Inc. Dated as of March 13, 2024

from 8-K 133 pages Agreement and Plan of Merger Among: First Wave Biopharma, Inc.; Immuno Merger Sub I, Inc.; Immuno Merger Sub II, LLC; and Immunogenx, Inc. Dated as of March 13, 2024

from 8-K 76 pages Agreement and Plan of Merger Among AzurRx Biopharma, Inc., Alpha Merger Sub, Inc., First Wave Bio, Inc. and Fortis Advisors LLC, as Shareholders’ Representative Dated as of September 13, 2021